Individuals suffering from chronic kidney insufficiency are at risk of developing cardiovascular, skeletal, and metabolic complications, which is why their quality of life progressively declines over the course of years [1] [2] [3] [4]. One of the most prevalent signs of chronic kidney insufficiency is anemia, seen in up to 50% of cases [1] [4]. Anemia stems from the inability of the damaged kidneys to produce erythropoietin, thus promoting various cardiovascular disorders, such as left ventricular hypertrophy, hypertension, angina, and heart failure [1] [4]. In fact, drowsiness, fatigue, and an overall lack of energy are encountered in the majority of patients, along with pruritus and pain [5]. Dyslipidemia is a frequent finding and contributes to the appearance of cardiovascular diseases, which is the cause of death in up to 40% of cases [1] [6]. Renal osteodystrophy is a term denoting the pathological changes of the skeletal system that arise in the setting of chronic kidney disease and its four subtypes (osteitis fibrosa cystica, osteomalacia, adynamic bone disease, and mixed osteodystrophy) are responsible for abnormal rates of bone loss and bone growth in these patients, as well as persistent albuminuria and proteinuria [1]. Electrolyte and hormone abnormalities (particularly hyperphosphatemia and changes in the levels of parathyroid hormone, or PTH) arise at later stages and have a severe effect on morbidity [1] [6].

The diagnosis of chronic kidney disease may not be easy to attain early on, which is why a thorough laboratory assessment is necessary. Some definitions interpret chronic kidney insufficiency as kidney damage in the presence of reduced albumin levels due to reduced kidney function (estimated by calculating the glomerular filtration rate, or GFR, based on creatinine levels) that persists for at least three months [1] [3]. For this reason, a complete biochemical workup consisting of serum electrolytes, urea, albumin, and most importantly creatinine, together with urinalysis to evaluate protein loss, is crucial to make the diagnosis [1]. Hyperphosphatemia and hyperparathyroidism are common findings, whereas a complete blood count (CBC) reveals anemia with normochromic and normocytic characteristics, thus excluding causes such as iron or vitamin B12 deficiency [1]. The key step of the workup is to determine the GFR and patients are classified based on the results [1] [3]:

• Stage 1 - GFR is ≥ 90 mL/min/1.73 m2 with loss of albumin through urine
• Stage 2 - GFR values between 60-89 mL/min/1.73 m2
• Stage 3 - GFR values between 30-59 mL/min/1.73 m2
• Stage 4 - GFR values between 15-29 mL/min/1.73 m2
• Stage 5 (also known as end-stage renal disease) - GFR is < 15 mL/min/1.73 m2

To make an exact value of the GFR, a 24-hour urine collection of creatinine is used over serum values [1].

The primary goal of CKI treatment is to slow the progression of the disease and manage symptoms. This often involves controlling blood pressure, managing blood sugar levels in diabetic patients, and reducing protein intake. Medications such as ACE inhibitors or angiotensin receptor blockers (ARBs) are commonly prescribed to protect kidney function. Lifestyle changes, including a balanced diet, regular exercise, and smoking cessation, are also recommended. In advanced stages, dialysis or kidney transplantation may become necessary.

The prognosis for CKI varies depending on the stage at diagnosis and the underlying cause. Early detection and management can significantly slow disease progression and improve quality of life. However, if left untreated, CKI can lead to end-stage renal disease (ESRD), requiring dialysis or transplantation. Regular monitoring and adherence to treatment plans are crucial for maintaining kidney function and preventing complications.

CKI can result from a variety of causes, with diabetes and high blood pressure being the most common. Other potential causes include glomerulonephritis (inflammation of the kidney's filtering units), polycystic kidney disease (a genetic disorder), prolonged obstruction of the urinary tract, and recurrent kidney infections. Certain medications and toxins can also contribute to kidney damage over time.

CKI is a global health concern, affecting millions of people worldwide. It is more prevalent in older adults, with risk factors including diabetes, hypertension, obesity, and a family history of kidney disease. The incidence of CKI is rising, partly due to the increasing prevalence of diabetes and hypertension. It is more common in certain ethnic groups, including African Americans, Hispanics, and Native Americans.

CKI involves a complex interplay of factors leading to the gradual loss of kidney function. Initially, damage to the nephrons (the functional units of the kidney) reduces the kidney's ability to filter blood effectively. This leads to compensatory mechanisms, such as hyperfiltration in remaining nephrons, which can cause further damage. Over time, this cycle results in scarring and fibrosis of kidney tissue, reducing its functional capacity.

Preventing CKI involves managing risk factors and maintaining a healthy lifestyle. Regular monitoring and control of blood pressure and blood sugar levels are crucial. A diet low in salt and protein, along with regular physical activity, can help maintain kidney health. Avoiding smoking and limiting alcohol intake are also beneficial. For individuals at higher risk, regular kidney function tests can aid in early detection and intervention.

Chronic Kidney Insufficiency is a progressive condition characterized by a gradual decline in kidney function. Early stages may be asymptomatic, but as the disease progresses, symptoms and complications can arise. Diagnosis involves blood and urine tests, imaging studies, and sometimes a kidney biopsy. Treatment focuses on slowing disease progression and managing symptoms through lifestyle changes and medications. Early detection and management are key to improving outcomes and quality of life.

If you have been diagnosed with CKI, it's important to work closely with your healthcare provider to manage the condition. Regular check-ups and adherence to treatment plans can help slow disease progression. Lifestyle changes, such as a healthy diet, regular exercise, and avoiding smoking, play a crucial role in maintaining kidney health. Understanding your condition and actively participating in your care can empower you to make informed decisions and improve your overall well-being.

1. Thomas R, Kanso A, Sedor JR. Chronic Kidney Disease and Its Complications. Prim Care. 2008;35(2):329-vii.
2. Coresh J, Selvin E, Stevens LA, et al. Prevalence of chronic kidney disease in the United States. JAMA. 2007;298:2038–2047.
3. Levey AS, Eckardt KU, Tsukamoto Y, et al. Definition and classification of chronic kidney disease: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO) Kidney Int. 2005;67:2089–2100.
4. McClellan W, Aronoff SL, Bolton WK, et al. The prevalence of anemia in patients with chronic kidney disease. Curr Med Res Opin. 2004;20:1501–1510.
5. Almutary H, Bonner A, Douglas C. Symptom burden in chronic kidney disease: a review of recent literature. J Ren Care. 2013;39(3):140-150.
6. Parmar MS. Chronic renal disease. BMJ : British Medical Journal. 2002;325(7355):85-90.